[{"address1": "Ugland House", "address2": "PO Box 309", "city": "Grand Cayman", "zip": "KY1-1104", "country": "Cayman Islands", "phone": "848 230 7430", "website": "https://www.adlainortye.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trial to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; AN1025, an oral small molecule degrader of \u00df-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands.", "fullTimeEmployees": 127, "companyOfficers": [{"maxAge": 1, "name": "Mr. Yang  Lu", "age": 44, "title": "CEO & Chairman", "yearBorn": 1980, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kaiyang  Tang", "age": 59, "title": "President", "yearBorn": 1965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Xiaofeng  Ye", "title": "Interim CFO and VP of Business Development & Commercialization Strategy", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Victoria Elizabeth Demby Ph.D.", "age": 53, "title": "Senior VP & Global Head of Regulatory Affairs", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ngai Chiu  Tse M.D., Ph.D.", "age": 56, "title": "Head of Research & Development", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.26, "open": 2.27, "dayLow": 2.2, "dayHigh": 2.3271, "regularMarketPreviousClose": 2.26, "regularMarketOpen": 2.27, "regularMarketDayLow": 2.21, "regularMarketDayHigh": 2.3271, "payoutRatio": 0.0, "forwardPE": -1.3950617, "volume": 6021, "regularMarketVolume": 6021, "averageVolume": 8632, "averageVolume10days": 8000, "averageDailyVolume10Day": 8000, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 83394680, "fiftyTwoWeekLow": 1.85, "fiftyTwoWeekHigh": 17.48, "priceToSalesTrailing12Months": 16.678936, "fiftyDayAverage": 2.15194, "twoHundredDayAverage": 3.307235, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 191724816, "profitMargins": 0.0, "floatShares": 52398012, "sharesOutstanding": 31236900, "sharesShort": 3777, "sharesShortPriorMonth": 3008, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0001, "heldPercentInsiders": 0.06957, "heldPercentInstitutions": 0.00182, "shortRatio": 0.89, "shortPercentOfFloat": 0.0001, "impliedSharesOutstanding": 36900300, "bookValue": 1.446, "priceToBook": 1.5629323, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -54065000, "trailingEps": -6.18, "forwardEps": -1.62, "enterpriseToRevenue": 38.345, "enterpriseToEbitda": -3.016, "52WeekChange": -0.7209877, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 2.26, "targetHighPrice": 9.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 97987000, "totalCashPerShare": 0.885, "ebitda": -63570000, "totalDebt": 39528000, "quickRatio": 1.804, "currentRatio": 1.846, "totalRevenue": 5000000, "debtToEquity": 74.064, "revenuePerShare": 0.215, "returnOnAssets": -0.4641, "grossProfits": 5000000, "freeCashflow": -48734876, "operatingCashflow": -66700000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -12.9338, "financialCurrency": "USD", "symbol": "ANL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.0, "regularMarketPrice": 2.26, "marketState": "CLOSED", "shortName": "Adlai Nortye Ltd.", "longName": "Adlai Nortye Ltd.", "exchange": "NGM", "messageBoardId": "finmb_1830112145", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1740781437, "regularMarketTime": 1740776402, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1695994200000, "postMarketChangePercent": 0.0, "postMarketPrice": 2.26, "postMarketChange": 0.0, "regularMarketChange": 0.0, "regularMarketDayRange": "2.21 - 2.3271", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 8632, "fiftyTwoWeekLowChange": 0.40999997, "fiftyTwoWeekLowChangePercent": 0.2216216, "fiftyTwoWeekRange": "1.85 - 17.48", "fiftyTwoWeekHighChange": -15.219999, "fiftyTwoWeekHighChangePercent": -0.87070936, "fiftyTwoWeekChangePercent": -72.09877, "epsTrailingTwelveMonths": -6.18, "epsForward": -1.62, "epsCurrentYear": -0.88, "priceEpsCurrentYear": -2.5681818, "fiftyDayAverageChange": 0.10805988, "fiftyDayAverageChangePercent": 0.0502151, "twoHundredDayAverageChange": -1.047235, "twoHundredDayAverageChangePercent": -0.3166497, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-09-29", "cryptoTradeable": false, "displayName": "Adlai Nortye", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]